Our latest preclinical studies in large animals have shown that MTC-Y can deliver insulin effectively and painlessly through the skin, paving the way for further development and clinical trials.
Don’t miss our CTO, Paweł Biernat‘s presentation on October 28 at 3:52 PM in Track 5A (Marina Ballroom III/IV). Learn how MTC-Y can revolutionize drug delivery, offering improved patient compliance, reduced side effects, and enhanced efficacy.
Visit us at booth #110 to explore the full potential of MTC-Y and discuss collaboration opportunities! We look forward to connecting with you at PODD 2024!